Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178588
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2023-12-09
Brief Title:
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced Recurrent or Metastatic Cholangiocarcinoma
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Organization Data
Organization:
University of Kansas Medical Center
Class:
OTHER
Study ID:
STUDY00150700
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Kansas Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Anup Kasi
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Kansas Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |